Pace Analytical® Expands COVID-19 Monitoring Services to Include Variants
Communities and businesses look to mitigate risk and prepare for variant outbreaks through quantitative wastewater monitoring of virus RNA. Minneapolis, […]
Communities and businesses look to mitigate risk and prepare for variant outbreaks through quantitative wastewater monitoring of virus RNA. Minneapolis, […]
Pace Analytical® Receives 2020 EBJ Business Achievement Award for COVID-19 Wastewater Surveillance Testing Service Environmental Business Journal Recognizes Environmental Industry
Pace Analytical® Environmental Manager Receives Outstanding Service Award from ASTM International Thomas Patten recognized by international standards organization for water
Pace Analytical® Chief Compliance Officer Appointed to California Environmental Laboratory Technical Advisory Committee Judy Morgan of Pace joins group providing
Find your purpose Pace® Life Sciences provides integrated CMC drug development and GMP testing solutions to the biopharmaceutical, pharmaceutical, and
Acquisition allows Pace Life Sciences to serve pharmaceutical and biopharmaceutical companies from early-stage product development through phase II clinical trial material manufacturing
Greg Kupp is the President of Pace® Life Sciences for Pace®, which includes the operations in Oakdale, Minnesota, and San
Judith Morgan joined Pace® in 2015 as Vice President and Chief Compliance/Training Officer. Following an exceptional 24-year career at ESC
Kyle Korzenowski has over 25 years of experience driving technology-enabled business improvement within multiple industries ranging from financial services to
Nicole Ott joined Pace® in 2017 with over 10 years of experience and serves as Vice President of Human Resources.